LAKE FOREST, Calif., December 17, 2025--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ICL™) for ...

Staar Surgical, a manufacturer of the Implantable Collamer Lens, has delayed a shareholder vote on Alcon’s planned $1.6 billion takeover offer for the fourth time since October. In October, the vote ...

Investing.com -- The civil war over STAAR Surgical Company (NASDAQ:STAA) raged Wednesday as the lens maker’s largest shareholder, Broadwood Partners, announced it sees a path to a $50-per-share ...

While STAAR’s stock rose 4.6% on Friday, up 4.2% on the week, a significant gap remains. With the stock still trading more than $5.50 below the $30.75 offer price, arbitrage traders are signaling a ...

STAAR Surgical (STAA) rose 4.4% in after-hours trading after proxy adviser ISS recommended that shareholders vote to approve Alcon's revised $30.75 a share offer. The ISS news comes after rival proxy ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ICL™) for vision ...

London-based Sand Grove Capital Management acquired 829,123 shares of STAAR Surgical Company in the third quarter. The position was worth about $22.28 million at quarter-end. This new stake accounts ...

Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which together own 30.2% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ICL™) for vision correction, ...

STAAR Surgical (STAA) rose 4.4% in after-hours trading after proxy adviser ISS recommended that shareholders vote to approve Alcon's revised $30.75 a share offer. ISS recommended a vote for Alcon and ...